Clinical Trial Update: Initial Attack on Latent Metastasis Using TAS-102 for ct DNA Identified Colorectal Cancer Patients After Curative Resection [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating TAS-102 (trifluridine/tipiracil) for preventing latent metastasis identified via circulating tumor DNA in colorectal cancer pati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Lonsurf (trifluridine/tipiracil)

Snippet

Sponsor: National Cancer Center Hospital East | Conditions: Colorectal Neoplasms, Trifluridine and Tipiracil | Phase 3 | Status: COMPLETED | Results posted: 2026-01-21